A phase 2, open‐label study of single dose dupilumab in children aged 6 months to < 6 years with severe uncontrolled atopic dermatitis: Pharmacokinetics, safety and efficacy
Journal of the European Academy of Dermatology and Venereology | Sep 11, 2020
Family history of psoriasis, psychological stressors, and tobacco use are associated with the development of tumor necrosis factor-α inhibitor-induced psoriasis: A case-control study
Journal of the American Academy of Dermatology | Sep 08, 2020
Most read this week